MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience ROCE Ratio 2011-2026 | VIVO
Annual ROCE Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.43 | 23.11 | 17.39 | 12.26 | 19.65 | 19.4 | 23.35 | 33.36 | 32.1 | 36.97 | 34.49 | 28.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.97 | 12.26 | 24.5 |
Quarterly ROCE Ratio Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.97 | 22.37 | 17.49 | 21.32 | 20.77 | 21.34 | 36.04 | 41.25 | 42.12 | 34.53 | 28.65 | 21.7 | 14.41 | 17.23 | 19.19 | 20.9 | 23.75 | 22.67 | 24.49 | 22.6 | 21.52 | 22.4 | 28.32 | 32.41 | 33.31 | 36.87 | 43.82 | 46.4 | 50.08 | 49.9 | 49.2 | 48.68 | 48.36 | 47.97 | 51.23 | 53.31 | 53.04 | 55.12 | 53.18 | 51.89 | 53.56 | 51.22 | 46.92 | 45.39 | 43.3 | 21.79 | 7.31 | 7.08 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 55.12 | 7.08 | 34.09 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 17.65 | 3.67 % | $ 186 M |  China |
 |
Agilent Technologies
A
|
25.0 | $ 118.75 | 1.04 % | $ 36.1 B |  USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 20.84 | 0.68 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.59 | - | $ 2.12 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.63 | 0.11 % | $ 684 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 186.62 | 0.66 % | $ 9.25 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 430.03 | -0.07 % | $ 12.4 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.12 | 1.44 % | $ 457 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 3.97 | -21.17 % | $ 368 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.7 | -1.81 % | $ 1.11 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 18.29 | -2.4 % | $ 409 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 215.11 | 4.03 % | $ 21.2 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 90.73 | 1.35 % | $ 11.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.06 | 2.31 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
-33.64 | $ 5.96 | 7.1 % | $ 353 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 123.29 | 1.62 % | $ 10.2 B |  Irlanda |
 |
Illumina
ILMN
|
-35.1 | $ 141.08 | 1.45 % | $ 22.4 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 5.1 | 2.0 % | $ 213 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.93 | 0.02 % | $ 2.69 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.01 | 0.1 % | $ 8.89 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-125.14 | $ 2.15 | -1.49 % | $ 4.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 86.12 | 0.35 % | $ 5.81 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 473.2 | 1.38 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.6 | 0.45 % | $ 61.9 M | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 258.91 | 0.69 % | $ 21.5 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 60.0 | 5.82 % | $ 3.59 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 141.31 | -0.27 % | $ 6.61 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.29 | 0.22 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 191.25 | 0.21 % | $ 21.2 B | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 352.11 | 2.73 % | $ 21 B | USA |